• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨质疏松症治疗中的生活质量结局:欧洲骨质疏松症基金会生活质量问卷的编制

Quality of life as outcome in the treatment of osteoporosis: the development of a questionnaire for quality of life by the European Foundation for Osteoporosis.

作者信息

Lips P, Cooper C, Agnusdei D, Caulin F, Egger P, Johnell O, Kanis J A, Liberman U, Minne H, Reeve J, Reginster J Y, de Vernejoul M C, Wiklund I

机构信息

Department of Endocrinology, Academisch Ziekenhuis Vrije Universiteit, Amsterdam, The Netherlands.

出版信息

Osteoporos Int. 1997;7(1):36-8. doi: 10.1007/BF01623457.

DOI:10.1007/BF01623457
PMID:9102060
Abstract

The morbidity of osteoporosis is caused by fractures. Vertebral fractures lead to pain and disability and a decrease in quality of life. A Working Party of the European Foundation for Osteoporosis has developed a specific questionnaire for patients with established vertebral osteoporosis. This questionnaire is intended for use in clinical trials. The questionnaire consists of questions and visual analogue scales in the following domains: pain, activities of daily living, jobs around the house, mobility, leisure and social activities, general health perception and mood. The questionnaire has been translated from English into French, German, Italian, Hebrew, Swedish and Dutch. The questionnaire is currently being validated in a multicentre study involving patients with stable osteoporosis and control subjects. Preliminary results indicate that the reproducibility is sufficient and that the questionnaire is able to discriminate between patients with vertebral osteoporosis and control subjects.

摘要

骨质疏松症的发病率是由骨折引起的。椎体骨折会导致疼痛、残疾以及生活质量下降。欧洲骨质疏松症基金会的一个工作小组为已确诊的椎体骨质疏松症患者制定了一份特定问卷。该问卷旨在用于临床试验。问卷由以下领域的问题和视觉模拟量表组成:疼痛、日常生活活动、家务、行动能力、休闲和社交活动、总体健康认知和情绪。该问卷已从英语翻译成法语、德语、意大利语、希伯来语、瑞典语和荷兰语。目前正在一项涉及稳定型骨质疏松症患者和对照受试者的多中心研究中对该问卷进行验证。初步结果表明其再现性足够,且该问卷能够区分椎体骨质疏松症患者和对照受试者。

相似文献

1
Quality of life as outcome in the treatment of osteoporosis: the development of a questionnaire for quality of life by the European Foundation for Osteoporosis.骨质疏松症治疗中的生活质量结局:欧洲骨质疏松症基金会生活质量问卷的编制
Osteoporos Int. 1997;7(1):36-8. doi: 10.1007/BF01623457.
2
Quality of life in patients with vertebral fractures: validation of the Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO). Working Party for Quality of Life of the European Foundation for Osteoporosis.椎体骨折患者的生活质量:欧洲骨质疏松症基金会生活质量问卷(QUALEFFO)的验证。欧洲骨质疏松症基金会生活质量工作小组。
Osteoporos Int. 1999;10(2):150-60. doi: 10.1007/s001980050210.
3
The development of a European questionnaire for quality of life in patients with vertebral osteoporosis.一份针对椎体骨质疏松症患者生活质量的欧洲调查问卷的编制。
Scand J Rheumatol Suppl. 1996;103:84-5; discussion 86-8. doi: 10.3109/03009749609103757.
4
[Quality of life assessment in osteoporotic patients with and without vertebral fractures].[有和无椎体骨折的骨质疏松症患者的生活质量评估]
Med Pregl. 2005 Sep-Oct;58(9-10):453-8. doi: 10.2298/mpns0510453v.
5
Impact of osteoporosis-associated vertebral fractures on health-related quality of life in the Mexican population.骨质疏松相关椎体骨折对墨西哥人群健康相关生活质量的影响。
Rev Invest Clin. 2014 May-Jun;66(3):225-33.
6
Validity and reliability of the Italian version of the ECOS-16 questionnaire in postmenopausal women with prevalent vertebral fractures due to osteoporosis.ECOS-16问卷意大利语版本在患有骨质疏松症所致椎体骨折的绝经后女性中的效度和信度
Clin Exp Rheumatol. 2007 May-Jun;25(3):390-403.
7
[QOL in osteoporotic patients with vertebral fractures].[椎体骨折骨质疏松患者的生活质量]
Clin Calcium. 2004 Mar;14(3):442-6.
8
Development and validation of the mini-osteoporosis quality of life questionnaire (OQLQ) in osteoporotic women with back pain due to vertebral fractures. Osteoporosis Quality of Life Study Group.针对因椎体骨折导致背痛的骨质疏松症女性,开发并验证小型骨质疏松症生活质量问卷(OQLQ)。骨质疏松症生活质量研究组。
Osteoporos Int. 1999;10(3):207-13. doi: 10.1007/s001980050217.
9
[The impact of subclinical vertebral fractures on health-related quality of life in women with osteoporosis].[亚临床椎体骨折对骨质疏松症女性健康相关生活质量的影响]
Medicina (Kaunas). 2006;42(9):744-50.
10
The reliability and validity of the Turkish version of Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO).欧洲骨质疏松症基金会生活质量问卷(QUALEFFO)土耳其语版本的信度和效度。
Clin Rheumatol. 2003 Feb;22(1):18-23. doi: 10.1007/s10067-002-0653-6.

引用本文的文献

1
Development and validation of the osteoporosis scale among the system of quality of life instruments for chronic diseases QLICD-OS (V2.0).骨质疏松症量表的制定与验证:慢性病生命质量测定量表体系之骨质疏松症量表(QLICD-OS,V2.0)。
BMC Geriatr. 2024 May 7;24(1):407. doi: 10.1186/s12877-024-05019-9.
2
How quality of life is measured in studies of nutritional intervention: a systematic review.营养干预研究中生活质量的测量方法:系统评价。
Health Qual Life Outcomes. 2024 Jan 24;22(1):9. doi: 10.1186/s12955-024-02229-y.
3
Health-related quality of life in osteoporosis: a systematic review of measurement properties of the QUALEFFO-41.

本文引用的文献

1
Recommendations for the registration of new chemical entities used in the prevention and treatment of osteoporosis.用于预防和治疗骨质疏松症的新化学实体注册建议。
Calcif Tissue Int. 1995 Oct;57(4):247-50. doi: 10.1007/BF00298877.
2
The Sickness Impact Profile: development and final revision of a health status measure.疾病影响量表:一种健康状况测量工具的开发与最终修订
Med Care. 1981 Aug;19(8):787-805. doi: 10.1097/00005650-198108000-00001.
3
Measuring health status: a new tool for clinicians and epidemiologists.衡量健康状况:临床医生和流行病学家的新工具。
骨质疏松症相关生活质量:QUALEFFO-41 测量特性的系统评价。
Osteoporos Int. 2024 May;35(5):745-757. doi: 10.1007/s00198-023-07005-0. Epub 2024 Jan 9.
4
Effects of resistance and balance exercises for athletic ability and quality of life in people with osteoporotic vertebral fracture: Systematic review and meta-analysis of randomized control trials.抗阻和平衡训练对骨质疏松性椎体骨折患者运动能力和生活质量的影响:随机对照试验的系统评价和荟萃分析
Front Med (Lausanne). 2023 Mar 9;10:1135063. doi: 10.3389/fmed.2023.1135063. eCollection 2023.
5
Cost-Effectiveness of Denosumab for the Treatment of Postmenopausal Osteoporosis in South Korea.地诺单抗治疗韩国绝经后骨质疏松症的成本效益
J Bone Metab. 2022 May;29(2):83-92. doi: 10.11005/jbm.2022.29.2.83. Epub 2022 May 31.
6
Percutaneous vertebroplasty versus conservative treatment and placebo in osteoporotic vertebral fractures: meta-analysis and critical review of the literature.经皮椎体成形术与保守治疗和安慰剂治疗骨质疏松性椎体骨折的比较:荟萃分析和文献综述。
Eur Radiol. 2021 Nov;31(11):8542-8553. doi: 10.1007/s00330-021-08018-1. Epub 2021 May 7.
7
Comparison of the Characteristics of Back Pain in Women with Postmenopausal Osteoporosis with and without Vertebral Compression Fracture: A Retrospective Study at a Single Osteoporosis Center in Poland.比较波兰单一骨质疏松症中心绝经后骨质疏松症伴与不伴椎体压缩性骨折女性背痛特征的回顾性研究。
Med Sci Monit. 2021 Feb 18;27:e929853. doi: 10.12659/MSM.929853.
8
Efficacy of annual zoledronic acid in initial percutaneous kyphoplasty patients with osteoporotic vertebral compression fractures: a 3-year follow-up study.初始经皮椎体后凸成形术治疗骨质疏松性椎体压缩骨折患者中每年唑来膦酸的疗效:一项 3 年随访研究。
Osteoporos Int. 2021 Jul;32(7):1429-1439. doi: 10.1007/s00198-020-05816-z. Epub 2021 Jan 18.
9
Quality of life and factors that affect osteoporotic hip fracture patients in Thailand.泰国骨质疏松性髋部骨折患者的生活质量及影响因素。
Osteoporos Sarcopenia. 2018 Dec;4(4):140-144. doi: 10.1016/j.afos.2018.11.082. Epub 2018 Dec 1.
10
Pharmaceutical care and health related quality of life outcomes over the past 25 years: Have we measured dimensions that really matter?过去25年的药学服务与健康相关生活质量结果:我们所测量的维度真的重要吗?
Int J Clin Pharm. 2018 Feb;40(1):3-14. doi: 10.1007/s11096-017-0582-8. Epub 2018 Jan 10.
J R Coll Gen Pract. 1985 Apr;35(273):185-8.
4
A study of complaints and their relation to vertebral destruction in patients with osteoporosis.一项关于骨质疏松症患者的疼痛主诉及其与椎体破坏关系的研究。
Bone Miner. 1990 Mar;8(3):217-29. doi: 10.1016/0169-6009(90)90107-q.
5
The Mediterranean Osteoporosis (MEDOS) Study questionnaire.地中海骨质疏松症(MEDOS)研究问卷。
Clin Rheumatol. 1991 Mar;10(1):54-72. doi: 10.1007/BF02208034.
6
Guidelines for clinical trials in osteoporosis. A position paper of the European Foundation for Osteoporosis and Bone Disease.骨质疏松症临床试验指南。欧洲骨质疏松症与骨病基金会立场文件。
Osteoporos Int. 1991 Jun;1(3):182-8. doi: 10.1007/BF01625451.
7
Quality of life and vertebral osteoporosis.生活质量与椎体骨质疏松症。
Osteoporos Int. 1992 Jul;2(4):161-3. doi: 10.1007/BF01623919.
8
Quality of life measures in health care. I: Applications and issues in assessment.医疗保健中的生活质量测量。I:评估中的应用与问题。
BMJ. 1992 Oct 31;305(6861):1074-7. doi: 10.1136/bmj.305.6861.1074.
9
Quality of life measures in health care. II: Design, analysis, and interpretation.医疗保健中的生活质量测量。II:设计、分析与解读。
BMJ. 1992 Nov 7;305(6862):1145-8. doi: 10.1136/bmj.305.6862.1145.
10
Validating the SF-36 health survey questionnaire: new outcome measure for primary care.验证SF-36健康调查问卷:初级保健的新结局指标。
BMJ. 1992 Jul 18;305(6846):160-4. doi: 10.1136/bmj.305.6846.160.